For Prelims: Tuberculosis, Drug-susceptible tuberculosis, Nucleic acid amplification test, Verbal autopsy
For Mains: Society: Health and public health programmes; Governance: Government schemes and service delivery
Source:PIB
The Hindu
Indian Express
New update
New facts from Indian Express, 13 November 2026
- India's TB incidence estimate is under review, with an update expected in early 2027
- National TB surveys: 1955-1958 and 2020-2021
- 2025 district surveillance: 50 representative districts
- Global TB deaths in 2025: 1.13 million
- 2025 India TB diagnoses: 25.3 lakh
New facts from PIB, 13 November 2026
- TB mortality rate declined from 28 deaths per lakh population in 2015 to 18 deaths per lakh in 2025
- 96% of programme funding requirements are met through domestic resources
- Over 25 crore people covered under intensified screening (implied by 11 crore X-rays and 3 crore tests, but explicitly stated as 25 crore people)
New facts from Indian Express, 14 November 2026
- 46% of TB cases diagnosed using rapid diagnostic testing in 2025, up from 38% in 2024
- Global TB funding reduced by 14% while India's domestic funding increased
- India's estimated TB incidence is missing from the 2026 Global TB report pending district-level sentinel surveillance data
- WHO End TB targets: 35% death reduction by 2020, 75% by 2025, 90% by 2030, 95% by 2035 from 2015 baseline
- India missed its 2025 target of eliminating TB five years ahead of global deadline
- India breached the 2020 End TB milestone five years late
5 facts for one-day exams
SSC, railway, police and teaching exams ask direct questions like these.
- India's estimated TB mortality declined by 38% since 2015.
- Drug-susceptible TB treatment success reached 94% in India.
- The first intensified 100-day TB campaign began on 7 December 2024.
- Ni-kshay Poshan Yojana provides eligible patients financial assistance for nutrition during treatment.
- India declared 67,933 Panchayats TB-free in 2025.
The news
India has recorded a 38% reduction in estimated tuberculosis mortality since 2015, compared with a 35% global decline, and a 94% treatment success rate among patients with drug-susceptible tuberculosis, according to the World Health Organization's Global Tuberculosis Report 2026 released on 12 November 2026. The Ministry of Health and Family Welfare said the figures reflect progress under the National TB Elimination Programme, which combines early detection, rapid diagnostics, nutritional support and community outreach.
In 2025, 2.63 lakh deaths due to TB were reported. Between 7 December 2024 and 8 November 2026, the TB Mukt Bharat Abhiyaan brought over 25 crore people under screening activities, conducted more than 11 crore chest X-rays and over 3 crore nucleic acid amplification tests, and detected 48.64 lakh new TB cases, including 14.97 lakh asymptomatic cases. Officials said 96% of the TB programme's funding requirements were met through domestic resources.
Why in the news?
The WHO Global Tuberculosis Report 2026, released on 12 November 2026, documents India's 38% decline in TB mortality and 94% treatment success rate, making the progress official and comparable with global trends.
What is the National TB Elimination Programme?
The National TB Elimination Programme is the Government of India's centrally sponsored programme for tuberculosis control, run by the Ministry of Health and Family Welfare. It was earlier known as the Revised National Tuberculosis Control Programme, which began in 1993, and was renamed the National TB Elimination Programme in 2020. India's National Strategic Plan 2017-2025 set the goal of eliminating TB in the country by 2025, ahead of the global target of 2030 under the Sustainable Development Goals. The programme operates through a network of district tuberculosis centres and designated microscopy centres, and it is supported by the Nikshay web-based case-based monitoring system launched in 2012. The Ni-kshay Poshan Yojana, which provides direct benefit transfers for nutritional support to TB patients, was launched in April 2018.
How was the mortality decline measured?
The WHO report used evidence from multiple sources, including the Registrar General of India's Sample Registration System, community-based verbal autopsy assessments and programme data from the Ni-kshay portal, to strengthen TB mortality estimation. The Indian Council of Medical Research-National Institute for Research in Tuberculosis conducted a district-level TB prevalence survey in 50 representative districts in 2025; its findings are under technical discussion with WHO before an updated country profile is published.
What did the screening campaigns achieve and what remains?
The first intensified 100-day campaign began on 7 December 2024 across 347 high-priority districts in 33 States and Union Territories and was later expanded nationwide. A second campaign launched on 24 March 2026 focused on 1.58 lakh high-risk villages and wards, congregate settings and vulnerable populations. The detection of nearly 15 lakh asymptomatic cases shows the effectiveness of proactive screening in identifying individuals who might otherwise remain undiagnosed, officials said. In 2025, 67,933 panchayats were declared TB-free.
What patient support and technology are being used?
Under the Ni-kshay Poshan Yojana, eligible patients receive financial assistance towards nutritional requirements during treatment, while the Ni-kshay Mitra initiative mobilises nutritional and psychosocial support. The Ni-kshay digital platform supports patient tracking and treatment monitoring. AI tools are used for hotspot identification, prediction of high-risk cases and a chatbot called Khushi. The JOSH Teams initiative, involving designated Class-I officers, five NCC cadets and five My Bharat volunteers at block and ward levels, aims to strengthen youth participation in the elimination movement.
TB mortality decline: India and the world
| Region | Decline since 2015 |
|---|---|
| India | 38% |
| Global | 35% |
Facts and terms for exams
- Tuberculosis:
- Tuberculosis is an infectious disease caused by Mycobacterium tuberculosis, usually affecting the lungs.
- Drug-susceptible tuberculosis:
- Drug-susceptible tuberculosis is disease caused by bacteria that respond to standard first-line tuberculosis medicines.
- Nucleic acid amplification test:
- A nucleic acid amplification test detects genetic material of a pathogen by amplifying its nucleic acid.
- Verbal autopsy:
- Verbal autopsy is a method of assessing a probable cause of death using information obtained from people familiar with the deceased person's symptoms.
Why it matters for exams
Exams: UPSC, BPSC, UPPSC, MPPSC, RPSC RAS, SSC
Syllabus: Society: Health and public health programmes; Governance: Government schemes and service delivery
Common mistake: Examiners may swap the 38% Indian decline with the 35% global decline, or apply 94% treatment success to all TB cases; the success figure concerns drug-susceptible TB.
Mains question
India has achieved a 38% decline in TB mortality and a 94% treatment success rate. Examine the role of technology, nutritional support and community participation in this progress.
Stuck? Get it in one tap
Tuberculosis is an infectious disease, usually affecting the lungs. India uses screening and diagnostic tests to find cases early, including in people without symptoms. Treatment, nutritional assistance and community support help patients complete care.
- Society: Health and public health programmes
- Governance: Government schemes and service delivery
Related concepts: Tuberculosis, Drug-susceptible tuberculosis, Nucleic acid amplification test, Verbal autopsy
Practice questions
Pick an answer, then read the explanation.
- Q1Easy
Which ministry is responsible for India's National TB Elimination Programme?
Explanation: The Ministry of Health and Family Welfare is responsible for the National TB Elimination Programme. WHO publishes the global tuberculosis report, the Indian Council of Medical Research undertakes research, and the Registrar General of India supports mortality evidence through the Sample Registration System.
- Q2Hard
Consider the following statements regarding India's tuberculosis elimination efforts:
- 1.India recorded a 38% reduction in estimated tuberculosis mortality since 2015.
- 2.India achieved a 94% treatment success rate among patients with drug-susceptible tuberculosis.
- 3.The TB Mukt Bharat Abhiyaan detected 48.64 lakh new tuberculosis cases between 7 December 2024 and 8 November 2026.
Which of the statements given above are correct?
Explanation: 1. True: Estimated TB mortality declined by 38% since 2015. 2. True: The treatment success rate for drug-susceptible TB was 94%. 3. True: The Abhiyaan detected 48.64 lakh new cases during this period.
- Q3Medium
How many asymptomatic TB cases were identified through TB Mukt Bharat Abhiyaan screening between 7 December 2024 and 8 November 2026?
Explanation: Screening identified 14.97 lakh asymptomatic cases. The 48.64 lakh figure represents all new cases identified, while 11 lakh and 25 lakh are not the asymptomatic case count.
- Q4Medium
Why does the TB Mukt Bharat Abhiyaan proactively screen people without symptoms?
Explanation: Proactive screening can identify asymptomatic cases that might otherwise remain undiagnosed, enabling timely treatment and opportunities to reduce transmission. Nutritional support complements treatment, while screening and diagnostic tests help identify cases rather than restrict detection to known patients.
Frequently asked questions
1. How much did India's estimated TB mortality decline since 2015?
India's estimated TB mortality declined by 38% since 2015, compared with a 35% global decline.
2. What is India's TB treatment success rate in the WHO Global Tuberculosis Report 2026?
The treatment success rate is 94% among patients with drug-susceptible tuberculosis.
3. What support does Ni-kshay Poshan Yojana provide?
Eligible TB patients receive financial assistance towards their nutritional requirements during treatment.
4. How many asymptomatic cases were detected under TB Mukt Bharat Abhiyaan?
Screening identified 14.97 lakh asymptomatic cases between 7 December 2024 and 8 November 2026.
All sources
Original12 November 2026 · Read story
Merged12 November 2026 · Read story
Update13 November 2026 · Read story
Update13 November 2026 · Read story
Update14 November 2026 · Read story

